Health Canada authorizes drug remdesivir for severe COVID-19 cases
2020-07-29 from cbc.ca
Health Canada has authorized, with conditions, the drug remdesivir for patients with severe COVID-19, though Canada's top doctor says the supply is limited.
The drug — which will go by the brand name Veklury — is manufactured by Gilead Sciences Canada.
On Tuesday, Health Canada announced the drug is now authorized for use in adults and adolescents age 12 and older, with a body weight of at least 40 kilograms.
The company did not seek permission to use the drug to treat pregnant women or children under 12.
In April, a study run by the U.S. National Institutes of Health tested remdesivir versus usual care in 1,063 hospitalized coronavirus patients around the world. It found that the drug reduced the time it takes patients to recover by 31 per cent — 11 days on average versus 15 days for those just given usual care.
But Dr. Theresa Tam, chief public health officer of Canada, warned that "the supply with this company is very low globally."
Read more here